Post-Marketing Surveillance Of Olmesartan Medoxomil In Combination With Hydrochlorothiazide
Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
This is a Post-Marketing Surveillance study evaluating the Efficacy, Tolerability and Safety
of Olmesartan medoxomil 20 mg in combination with 12.5 MG of hydrochlorothiazide in subjects
with mild to moderate essential hypertension